Diagnosis of prostate cancer

JL Descotes - Asian journal of urology, 2019 - Elsevier
Diagnosis of prostate cancer (PCa) and adequate staging play a fundamental role for
clinical and patient care. Despite major advances in biology and imaging, rectal examination …

Research progress on deep learning in magnetic resonance imaging–based diagnosis and treatment of prostate cancer: a review on the current status and …

M He, Y Cao, C Chi, X Yang, R Ramin, S Wang… - Frontiers in …, 2023 - frontiersin.org
Multiparametric magnetic resonance imaging (mpMRI) has emerged as a first-line screening
and diagnostic tool for prostate cancer, aiding in treatment selection and noninvasive …

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

T Nordström, O Akre, M Aly, H Grönberg… - Prostate cancer and …, 2018 - nature.com
Background Screening for prostate cancer using prostate-specific antigen (PSA) alone leads
to un-necessary biopsying and overdiagnosis. PSA density is easily accessible, but early …

The use of prostate specific antigen density to predict clinically significant prostate cancer

I Yusim, M Krenawi, E Mazor, V Novack… - Scientific reports, 2020 - nature.com
The purpose of this study was to assess the predictive value of prostate specific antigen
density (PSAD) for detection of clinically significant prostate cancer in men undergoing …

Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7–10 prostate cancer in …

L Boesen, N Nørgaard, V Løgager, I Balslev… - European urology …, 2019 - Elsevier
Background Multiparametric magnetic resonance imaging (MRI) combined with prostate-
specific-antigen density (PSAd) enhances the detection of significant prostate cancer …

Prostate cancer screening: Continued controversies and novel biomarker advancements

A Tidd-Johnson, SA Sebastian, M Afaq… - Current …, 2022 - journals.lww.com
Prostate cancer (PCa) screening remains one of the most controversial topics in clinical and
public health. Despite being the second most common cancer in men worldwide …

Prostate specific antigen density as a predictor of clinically significant prostate cancer when the prostate specific antigen is in the diagnostic gray zone: defining the …

A Aminsharifi, L Howard, Y Wu, A De Hoedt… - The Journal of …, 2018 - auajournals.org
Purpose: We assessed the predictive value of prostate specific antigen density to detect
clinically significant prostate cancer, defined as prostate cancer grade group 2 or greater, in …

PSA density help to identify patients with elevated PSA due to prostate cancer rather than intraprostatic inflammation: a prospective single center study

SM Bruno, UG Falagario, N d'Altilia, M Recchia… - Frontiers in …, 2021 - frontiersin.org
The association between PSA density, prostate cancer (PCa) and BPH is well established.
The aim of the present study was to establish whether PSA density can be used as a reliable …

PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?

L Rico, L Blas, G Vitagliano, P Contreras… - … Oncology: Seminars and …, 2021 - Elsevier
Introduction Currently, a new subclassification of the Pi-RADS 3 lesions and subgroups is
being used: 3a (indolent or low-risk lesions with volume< 0.5 ml) and 3b (significant or high …

Deep learning network for segmentation of the prostate gland with median lobe enlargement in T2-weighted MR images: comparison with manual segmentation …

G Salvaggio, A Comelli, M Portoghese, G Cutaia… - Current problems in …, 2022 - Elsevier
Purpose Aim of this study was to evaluate a fully automated deep learning network named
Efficient Neural Network (ENet) for segmentation of prostate gland with median lobe …